Welcome to Shandong Zhonglian Chemical Co., Ltd. Equity Code:880747
26
2026
-
02
Driven by Both Compliance and Performance! Our Pharmaceutical Excipient Silicon Dioxide Empowers Pharmaceutical Preparation Quality Improvement
The development of the pharmaceutical industry is inseparable from innovations in excipient technology. In the future, our company will continue to increase R&D investment in the pharmaceutical excipient field, focusing on industry trends such as "generic drug consistency evaluation" and "innovative drug preparation optimization", launching products with stronger technological barriers to help global pharmaceutical enterprises improve preparation quality and safeguard patients’ health.
The stability, safety, and effectiveness of pharmaceutical preparations rely on high-quality excipients. Our company focuses on the pharmaceutical and healthcare field, launching pharmaceutical excipient silicon dioxide that meets global pharmacopoeial standards. With the dual advantages of "high compliance + high-performance compatibility", it is widely used in multiple dosage forms such as oral tablets, injections, and sustained-release preparations, becoming a core partner for pharmaceutical enterprises to optimize product formulations.
In the pharmaceutical excipient field, compliance is the core prerequisite for market access. Our pharmaceutical excipient silicon dioxide strictly complies with the three major standards of USP (United States Pharmacopeia), EP (European Pharmacopoeia), and CP (Chinese Pharmacopoeia). Through aseptic production processes, low heavy metal control (lead, arsenic, etc. ≤ 0.1ppm), and low ash content design (ash content < 0.5%), it ensures products meet the strict requirements of high-end scenarios such as injections and pediatric medications.
For example:
- To meet the production needs of orally disintegrating tablets, our products can optimize fluidity to improve tablet disintegration speed and drug dissolution rate.
- For sustained-release preparations, their stable physicochemical properties can assist in controlling drug release rate, ensuring continuous and stable drug efficacy.
From the perspective of product layout, our pharmaceutical excipient silicon dioxide covers multi-dimensional needs:
- For oral drugs: High-fluidity variants are launched to solve problems such as sticking and cracking during tablet compression.
- For injectable drugs: Aseptic-grade products are developed, eliminating microbial risks through terminal sterilization processes.
- For biopharmaceuticals: Customized low-endotoxin variants are provided to avoid interference of excipients with bioactive ingredients.
In addition, our company has established a "customized service system", which can adjust product parameters such as particle size and specific surface area according to clients’ preparation formulations (e.g., capsules, powders, ointments), realizing the upgrade from "standardized products" to "scenario-specific solutions".
The development of the pharmaceutical industry is inseparable from innovations in excipient technology. In the future, our company will continue to increase R&D investment in the pharmaceutical excipient field, focusing on industry trends such as "generic drug consistency evaluation" and "innovative drug preparation optimization", launching products with stronger technological barriers to help global pharmaceutical enterprises improve preparation quality and safeguard patients’ health.
Related Blog
Related Downloads
Service E-mail
Sales Add
Jinan City, Shandong Province,China
Production Add
Guangzhou City, Guangdong Province
